‘Selling a promise’
What Silicon Valley learned from the fall of Theranos. The company was founded in 2003 and "promised to upend the vast medical testing industry with a technology that could perform a range of health tests on just a small drop of blood." By 2013, Theranos was worth $10 billion, and its CEO, Elizabeth Holmes, was being ranked among the likes of Steve Jobs. Then, a few years later, it all came crashing down. Now, Holmes is about to face trial in the US on up to 12 fraud charges, and the whole industry seems to be paying close attention. Will this be a true reckoning for Silicon Valley? Kari Paul explores.
From The Guardian